"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
- Patient Information:
Details with Side Effects
No information is available on overdosage of humans. The oral LD50 of the drug ranged from 350-920 mg/kg in mice and 860-1050 mg/kg in rats. The symptoms which might be expected with an overdose of a systemically administered beta-1-adrenergic receptor inhibitor are bradycardia, hypotension and acute cardiac failure.
BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) Suspension is contraindicated in patients with:
- sinus bradycardia
- greater than a first degree atrioventricular block
- cardiogenic shock
- patients with overt cardiac failure
- hypersensitivity to any component of this product.
Last reviewed on RxList: 7/14/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Betoptic S Information
Betoptic S - User Reviews
Betoptic S User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.